Minneapolis, Minnesota, United States
Unique combination of operating (general management, COO) and transaction experience (M&A, investments, strategic partnerships) in medtech industry. Proven strategic leader with track record for execution. Executive experience serving in general management as well as leading multiple functional groups in large and smaller companies including functional responsibilities corporate development, international general management, health economics & reimbursement, marketing, quality, training/education and human resources. Experience leading mergers & acquisitions, private equity / venture capital investments and strategic planning including assessing organic and external investment opportunities, building and executing business cases / strategies, presenting recommendations to executive management/Board of Directors, deal structuring, financial modeling, negotiations, due diligence, managing integration teams and serving as a Board member/Board observer. Completed over 100 transactions with aggregate transaction value of $4 billion. Broad industry experience across healthcare (medical device, life sciences, biotech and services) and technology (software, e-commerce, telecommunications) markets. Experience in: - General management including P&L responsibility and cross-functional leadership - Corporate development (acquisitions, equity investments, licensing, strategic partnerships) - Investment banking (healthcare & technology) - Strategy development and execution - Health economics & reimbursement - Financial modeling and valuations - Venture capital / private equity - Member of Board of Directors and serving as Board Observer - Medical Device / MedTech / Technology industries
Promoted to establish, build and lead CSI’s International team and business. Led international expansion launching cardiovascular (coronary and peripheral) products in 40+ countries and growing sales from $0 to $20M run rate. CSI was acquired by Abbott in April 2023.
Corporate Development: developed strategies related to mergers & acquisitions, equity investments and distribution partnerships; led cross-functional teams in the development of the company's strategic plan. Health Economics & Reimbursement: developed health economics, reimbursement and healthcare policy strategies.
Served as independent consultant providing strategic advisory services to healthcare companies. Advisory services included general business strategy, M&A, strategic partnerships, fundraising, healthcare economics and reimbursement. Clients included businesses in coronary and peripheral vascular, neuromodulation and orthopedic markets.
Led global strategic market research and health economics & reimbursement strategy across all of St. Jude Medical's business units including atrial fibrillation, cardiac rhythm management, cardiovascular and neuromodulation businesses.
Led four functional groups contributing to transformational growth of St. Jude Medical's Cardiovascular Division growing revenue from $791M in 2007 to $1.3B in 2011 primarily due to revenue contributions from new growth drivers added via mergers & acquisitions.
Working with corporate and business unit teams, completed 30+ transactions including mergers & acquisitions, equity investments, structured financings, distribution, licensing and supply partnerships.
Start-up experience as founding member of a boutique investment bank. Transactions included acquisitions, licensing, strategic plan development, asset sales and growth equity investments. In 2009, the Mercanti Group was acquired by Imperial Capital LLC. The Mercanti Group (offices in Los Angeles, Minneapolis, New York and Seattle) was a results-oriented boutique merchant bank that embraced a fierce commitment to client service and creative financial solutions. The Mercanti professionals have significant Wall Street experience and were focused on providing customized financial advisory services to middle market companies and private equity funds in the consumer/retail, health care, technology and business services/manufacturing sectors. Mercanti offered companies and their financial sponsors the expertise and capabilities of a large investment bank coupled with the focused attention and energy of a small entrepreneurial firm.